Luteolin protects rat PC 12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keapl-Nrf2-ARE pathway

Journal of Neural Transmission, Supplementa

Volumn , Issue 72, 2007, Pages 57-67

  Wruck, C J ^a   Claussen, M ^a   Fuhrmann, G ^a   Romer L ^a   Schulz, A ^a   Pufe, T ^a   Waetzig, V ^a   Peipp, M ^a   Herdegen, T ^a   Gotz M E ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

flavonoids; Luteolin; MPP+; Nrf2; nuclear factor; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ANTIOXIDANT; FLAVONOID; HERBICIDE; KEAP1 PROTEIN, RAT; LUTEOLIN; NFE2L2 PROTEIN, RAT; PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BRAIN; CELL CULTURE; CELL STRAIN; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION; GENETICS; IN VITRO STUDY; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RAT; REPORTER GENE; UPREGULATION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ANTIOXIDANTS; BRAIN; CELL SURVIVAL; FLAVONOIDS; GENE EXPRESSION; GENES, REPORTER; HERBICIDES; LUTEOLIN; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PC12 CELLS; PROTEINS; RATS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 38449086141     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-73574-9_9     Document Type: Article

References (51)

1. Abdel-Wahab MH (2005) Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity - induced by 1-methyl-4-(2′- methylphenyl)-1, 2, 3, 6-tetrahydropyridine (2′-methyl-MPTP) in mice. J Biochem Mol Toxicol 19:32-41
2. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10 Suppl: S18-S25
3. Arora A, Nair MG, Strasburg GM (1998) Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Free Radic Biol Med 24:1355-1363
4. Boerboom A-MJF, Vermeulen M, van der Woude H, Bremer BI, Lee-Hilz YY, Kampman E, van Bladeren PJ, Rietjens IMCM, Aarts JMMJG (2006) Newly constructed stable reporter cell lines for mechanistic studies on electrophile-responsive element-mediated gene expression reveal a role for flavonoid planarity. Biochem Pharmacol 72:217-226
5. Burton NC, Kensler TW, Guilarte TR (2006) In vivo modulation of the Parkinsonian phenotype by Nrf2. NeuroToxicology 27:1094-1100
6. Dajas F, Rivera-Megret F, Blasina F, Arredondo F, Abin-Carriquiry JA, Costa G, Echeverry C, Lafon L, Heizen H, Ferreira M, Morquio A (2003) Neuroprotection by flavonoids. Braz J Med Biol Res 36:1613-1620
7. Datla KP, Christidou M, Widmer WW, Rooprai HK, Dexter DT (2001) Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. NeuroReport 12:3871-3875
8. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52:381-389
9. Gerlach M, Riederer P (1996) Animal models of Parkinson's disease. An empirical comparison with the phenomenology of the disease in man. J Neural Transm 103:987-1041
10. Götz ME, Künig G, Riederer P, Youdim MBH (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol Therapeut 63:37-122
11. Götz ME, Double K, Gerlach M, Youdim MBH, Riederer P (2004) The relevance of iron in the pathogenesis of Parkinson's disease. Ann NY Acad Sci 1012:193-208
12. Hara H, Ohta M, Ohta K, Kuno S, Adachi T (2003) Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. Mol Brain Res 119:125-131
13. Haridas V, Hanausek M, Nishimura G, Soehnge H, Gaikwad A, Narog M, Spears E, Zoltaszek R, Walaszek Z, Gutterman JU (2004) Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. J Clin Invest 113:65-73
14. Im H-I, Joo WS, Nam E, Lee ES, Hwang YJ, Kim YS (2005) Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice. J Pharmacol Sci 98:185-189
15. Ishige K, Schubert D, Sagara Y (2001) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30:433-446
16. Jakel RJ, Kern JT, Johnson DA, Johnson JA (2005) Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro. Toxicol Sci 87:176-186
17. Kawanishi S, Oikawa S, Murata M (2005) Evaluation for safety of antioxidant chemopreventive agents. Antioxid Redox Signal 7:1728-1739
18. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980
19. Langston JW, Irwin I, Langston EB, Forno LS (1984) Pargyline prevents MPTP-induced parkinsonism in primates. Science 225:1480-1482
20. Lee HJ, Noh YH, Lee DY, Kim Y, Kim KY, Chung YH, Lee WB, Kim SS (2005) Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. Eur J Cell Biol 84:897-905
21. Lee J-M, Moehlenkamp JD, Hanson JM, Johnson JA (2001) Nrf2-dependent activation of the antioxidant responsive element by tert-butylhydroquinone is independent of oxidative stress in IMR-32 human neuroblastoma cells. Biochem Biophys Res Commun 280:286-292
22. Lee J-M, Calkins M, Chan K, Kan YW, Johnson JA (2003) Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278:12029-12038
23. Lee J-M, Shih AY, Murphy TH, Johnson JA (2003) NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem 278:37948-37956
24. Lee JM, Johnson JA (2004) An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 37:139-143
25. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA (2005) Nrf2, a multi-organ protector? FASEB J 19:1061-1066
26. Lee-Hilz YY, Boerboom A-MJF, Westphal AH, van Berkel WJH, Aarts JMMJG, Rietjens IMCM (2006) Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chem Res Toxicol 19:1499-1505
27. Lestienne P, Nelson J, Riederer P, Jellinger K, Reichmann H (1990) Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. J Neurochem 55:1810-1812
28. Manach C, Scalbert C, Morand C, Rémésy C, Jiménez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727-747
29. Mandel S, Weinreb O, Amit T, Youdim MBH (2004) Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3- gallate: implications for neurodegenerative diseases. J Neurochem 89:1555-1569
30. Manfredi G, Xu Z (2005) Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5:77-87
31. Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827:65-75
32. Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28:57-87
33. Nagao A, Seki M, Kobayashi H (1999) Inhibition of xanthine oxidase by flavonoids. Biosci Biotechnol Biochem 63:1787-1790
34. Nguyen T, Huang HC, Pickett CB (2000) Transcriptional regulation of the antioxidant response element. J Biol Chem 275:15466-15473
35. Nguyen T, Sherratt PJ, Pickett CB (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43:233-260
36. Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB (2005) Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J Biol Chem 280:32485-32492
37. + and mitochondrial function. Life Sci 40:721-729
38. Przedborski S, Tieu K, Perier C, Vila M (2004) MPTP as a mitochondrial neurotoxic model of parkinson's disease. J Bioenerg Biomembr 36:375-379
39. Przedborski S, Ischiropoulos H (2005) Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid Redox Signal 7:685-693
40. Reichmann H, Riederer P, Seufert S (1990) Disturbances of the respiratory chain in brain from patients with Parkinson's disease. Mov Disord 5:28
41. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515-520
42. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54:823-827
43. Shen G, Hebbar V, Nair S, Xu C, Li W, Lin W, Keum Y-S, Han J, Gallo MA, Kong A-NT (2004) Regulation of Nrf2 transactivation domain activity. J Biol Chem 279:23052-23060
44. Shih AY, Li P, Murphy TH (2005) A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci 25:10321-10335
45. Shoulson I (1998) DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl and tocopherol antioxidative therapy of parkinsonism. Ann Neurol 44: S160-S166
46. Tanner CM (1989) The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci 12:49-54
47. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW (1999) Parkinson disease in twins: an etiologic study. JAMA 281:341-346
48. van Muiswinkel FL, Kuiperij HB (2005) The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders. Curr Drug Targets CNS Neurol Disord 4:267-281
49. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, Talalay P (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 101:2040-2045
50. Wright AF, Jacobson SG, Cideciyan AV, Roman AJ, Shu X, Vlachantoni D, McInnes RR, Riemersma RA (2004) Lifespan and mitochondrial control of neurodegeneration. Nat Genet 36:1153-1158
51. Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873.